Old dog, new trick: Maruho gains Japan rights to Pierre Fabre's hemangioma drug
This article was originally published in Scrip
Executive Summary
Propranolol may be the result of an earlier, simpler age of drug discovery in the 1960s but there is still life left in the aging beta-blocker yet, as shown by Laboratoires Pierre Fabre's new Japanese licensing deal for the product.